OAM
MNTA

Oberweis Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Oberweis Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-49,400
Closed -$576K – 153
2014
Q1 		$576K Buy
49,400
+4,800
+11% +$81.3K 0.12% 109
2013
Q4 		$789K Buy
44,600
+22,000
+97% +$370K 0.19% 82
2013
Q3 		$325K Buy
+22,600
New +$346K 0.09% 102

Other funds holding MNTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Oberweis Asset Management's MNTA Position: Q2 2014 in Review

Oberweis Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2014, closing a stake of 49,400 shares — an estimated $576K sold.

Oberweis Asset Management first reported a position in MNTA in Q3 2013 and held it in 3 quarters. The position peaked at $789K in Q4 2013. 148 funds tracked by Wall St. Rank hold MNTA as of Q2 2014.

  • Oberweis Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Oberweis Asset Management sold 49,400 Momenta Pharmaceuticals, Inc. shares in Q2 2014, an estimated $576K.
  • Oberweis Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
  • Oberweis Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $789K in Q4 2013.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2014.

Based on Oberweis Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.